NCT01556932
- Conditions
- Nausea, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
- Locations
-
- Virginia Commonwealth University Richmond, Virginia, United States
Clinical trial condition
Vomiting
Explore clinical trials studying Vomiting. Study availability and eligibility vary by location and protocol.
542 public trials
47 recruiting studies
Vomiting trial results
NCT00020657
- Conditions
- Nausea, Nausea and Vomiting, Pathological Conditions, Signs and Symptoms, +4 more
- Locations
-
- MBCCOP - Gulf Coast Mobile, Alabama, United States
- CCOP - Western Regional, Arizona Phoenix, Arizona, United States
- CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States
- CCOP - Colorado Cancer Research Program, Incorporated Denver, Colorado, United States
NCT00003817
- Conditions
- Nausea, Nausea and Vomiting, Pathological Conditions, Signs and Symptoms, +4 more
- Locations
-
- Hackensack University Medical Center Hackensack, New Jersey, United States
- University of Rochester Cancer Center Rochester, New York, United States
NCT00537875
- Conditions
- Nausea, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
- Locations
-
- National Research Institute of Tuberculosis and Lung Disease (NRITLD) Tehran, Iran
Completed
Intravenous Lidocaine in the Prevention of Postoperative Vomiting in Elective Tonsil Surgery
NCT01986309
- Conditions
- Nausea, Neurologic Manifestations, Pain, +7 more
- Locations
-
- División de Anestesia - Facultad de Medicina Pontificia Universidad Católica Santiago, Santiago Metropolitan, Chile
NCT02382666
- Conditions
- Chemotherapy-induced Nausea and Vomiting, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
- Locations
-
- Parexel Baltimore, Maryland, United States
- Conditions
- Chemotherapy-induced Nausea and Vomiting, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
- Locations
-
- Parexel Early Phase Unit Baltimore, Maryland, United States
Completed
An Open-Label, Randomized, Pivotal, Bioequivalence Study of Oral and Intravenous Rolapitant
NCT02285647
- Conditions
- Chemotherapy-induced Nausea and Vomiting, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
- Locations
-
- Parexel Baltimore, Maryland, United States
NCT00972595
- Conditions
- Chemotherapy-induced Nausea and Vomiting, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
- Locations
-
Not specified
Completed
A Study to Investigate the Safety and Tolerability of MK-0517 in Healthy Subjects (MK-0517-012)
NCT00990821
- Conditions
- Chemotherapy-induced Nausea and Vomiting, Nausea, Pathologic Processes, +6 more
- Locations
-
Not specified